OS Fund — 2016 Investments
3 investments dated 2016 · listed companies and verified rows first · show all
Elysium develops healthcare products focused on aging research and healthy aging rather than disease treatment.
HealthtechLongevityWellness & FitnessNew York City, US
Leonard Guarente, Ph.D.(Co-founder & Chief Scientist)Dan Alminana(COO, co-founder)inEric Marcotulli(CEO, co-founder)inJason AndersoninLeonard Guarente, PhD(Co-founder & Chief Scientist)David Fialkow(Director)
Co-investorsBreyer CapitalGaingelsSprint VcThe Venture CollectiveWestern Technology InvestmentGeneral Catalyst+2 more
Lygos was a performance materials company that used proprietary biology and chemistry to develop sustainable, high-performance ingredients and polymers.
BiotechCleantechClimate TechHealthtechNew MaterialsSan Francisco, US
Eric Steen(CEO)inJeffrey A. Dietrich(Executive Officer, Director)inJay D. Keasling(Director)Jeffrey Dietrich(CTO)in
BoardLeonard Katz(Director)
Co-investorsFifty YearsFundersClubJude GomilaLG Technology VenturesY Combinator10x Founders+10 more
San Francisco, US
Zachary Apte(Executive Officer, Director)Jessica Richman(Executive Officer, Director)
BoardJoseph Lonsdale(Director)Witt Wisebram(Director)
Co-investorsMilliways Ventures8VCDentsu VenturesSlow VenturesY Combinator
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




__Twitter.png)

.png)








